Influence of soluble fibrin on reaction kinetics of plasmin type 1 and type 2 with α2-antiplasmin
- 1 February 2003
- journal article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 14 (2) , 203-209
- https://doi.org/10.1097/00001721-200302000-00014
Abstract
This study investigates, by slow binding kinetics methods, reaction kinetics of both plasmin types 1 and 2 with alpha -antiplasmin in the presence of increasing concentrations of either epsilon-amino-caproic acid (EACA) or soluble fibrin. All curves of plasmin-alpha -antiplasmin interaction followed the same pattern, indicating reversible slow binding inhibition with an initial loose complex and a following tight complex. Without soluble fibrin or EACA, differences between plasmin types 1 and 2 could be seen in the initial loose complex formation. The presence of increasing concentrations of EACA slowed down the first step of the reaction (without any effect on the second step), resulting in increasing values for K. Plasmin type 1 demonstrated a steep slope of K at an EACA concentration of 1 mmol/l. In plasmin type 2, the increase of K started at higher EACA concentrations. The value for K at a high EACA concentration (100 mmol/l) was the same for both plasmin types. In contrast to EACA, increasing concentrations of soluble fibrin slowed down both reaction steps. At high concentrations of soluble fibrin, the inhibitory effect of alpha -antiplasmin was almost completely abolished. Our data demonstrate that the effect of soluble fibrin and the lysine analogue EACA on plasmin-antiplasmin reactions are different and that the use of lysine analogues does not mimic fibrin in laboratory analyses of plasmin inhibition. In addition, our data indicate theoretical differences between plasmin type 1 and plasmin type 2, when used for local thrombolytic therapy.(2) (2) (i initial) (i initial) (i initial) (i initial) (2)Keywords
This publication has 30 references indexed in Scilit:
- Fibrinolysis with Des-Kringle Derivatives of Plasmin and Its Modulation by Plasma Protease InhibitorsBiochemistry, 1998
- Functional Evaluation of the Structural Features of Proteases and Their Substrate in Fibrin Surface DegradationPublished by Elsevier ,1997
- Reaction of human α2‐antiplasmin and plasmin Stopped‐flow fluorescence kineticsFEBS Letters, 1996
- The influence of the nature of the asparagine 289-linked oligosaccharide on the activation by urokinase and lysine binding properties of natural and recombinant human plasminogens.Journal of Clinical Investigation, 1993
- On the molecular interactions between plasminogen-staphylokinase, α2-antiplasmin-formula> and fibrinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1992
- Serpin-serine protease binding kinetics: .alpha.2-antiplasmin as a model inhibitorBiochemistry, 1991
- Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-Sepharose, and fibrin cleaved by plasminBiochemistry, 1985
- Domains in human plasminogenJournal of Molecular Biology, 1984
- On the Rolw of the Carbohydrate Side Chains of Human Plasminogen in Its Interaction with α2‐Antiplasmin and FibrinEuropean Journal of Biochemistry, 1981
- Plasminogen: Purification from Human Plasma by Affinity ChromatographyScience, 1970